San Diego, CA, United States of America

Fei Shen

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Illumina Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fei Shen. Retrieved from https://idiyas.com/inventor/fei-shen-7lercv2b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fei Shen - Innovator in Hydrogel-Free Surface Functionalization

Introduction

Fei Shen is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the area of surface functionalization for sequencing technologies. His innovative work has led to the development of a unique patent that enhances the efficiency of sequencing processes.

Latest Patents

Fei Shen holds a patent titled "Hydrogel-Free Surface Functionalization for Sequencing." This invention addresses the challenges associated with traditional hydrogel methods, providing a more efficient and effective approach to surface functionalization in sequencing applications. He has 1 patent to his name, showcasing his commitment to advancing technology in this field.

Career Highlights

Fei Shen is currently employed at Illumina Corporation, a leading company in the genomics industry. His role at Illumina allows him to work on cutting-edge technologies that are transforming the landscape of genetic research and diagnostics. His expertise and innovative mindset have positioned him as a valuable asset to the company.

Collaborations

Fei Shen collaborates with talented colleagues, including Xiaoyu Ma and Weixian Xi. Together, they contribute to the advancement of technologies that are crucial for the future of genomics and biotechnology.

Conclusion

Fei Shen's work in hydrogel-free surface functionalization represents a significant advancement in sequencing technology. His contributions at Illumina Corporation and his innovative patent highlight his role as a key figure in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…